Program
AK139
A development code.
Its studies are mostly in Prurigo · Chronic Urticaria · Nasal Polyps · Dermatitis, Atopic · Rhinitis, Allergic, Seasonal, led by Akeso.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Akeso | 66 open or running | phase 2since Feb 3, 2026 | Feb 3, 2026 | Dec 27, 2026phase 2 · NCT07436221 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Feb 3, 2026First studies: 2 phase 2 studiesFirst studyNCT07436234, NCT07436221
- Mar 25, 2026Phase 2 study in Moderate-to-Severe Atopic DermatitisNCT07502222 · 168 planned
- Aug 5, 2026Phase 2 study in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)NCT07755371 · 75 planned · China
- Sep 24, 2026Phase 2 study in Chronic UrticariaNCT07875426 · 201 planned
- Oct 8, 2026Phase 2 study in Prurigo Nodularis (PN)NCT07883213 · 132 planned
Ahead
- Dec 27, 2026Primary completion: phase 2 study in AsthmaNCT07436221
- Apr 30, 2027Primary completion: phase 2 study in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)NCT07755371
- Aug 2027Primary completion: phase 2 study in Prurigo Nodularis (PN)NCT07883213
- Nov 2027Primary completion: phase 2 study in Moderate-to-Severe Atopic DermatitisNCT07502222
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 6 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07883213Prurigo Nodularis (PN) | 2 | Not yet recruiting | Aug 2027 | 132 |
| NCT07875426Chronic Urticaria | 2 | Not yet recruiting | Jan 8, 2029 | 201 |
| NCT07755371Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) · China | 2 | Not yet recruiting | Apr 30, 2027 | 75 |
| NCT07502222Moderate-to-Severe Atopic Dermatitis | 2 | Not yet recruiting | Nov 2027 | 168 |
| NCT07436234Rhinitis, Allergic, Seasonal · China | 2 | Not yet recruiting | Sep 30, 2026 | 111 |
| NCT07436221Asthma · China | 2 | Not yet recruiting | Dec 27, 2026 | 160 |
How it is read
Names in the registry
- “AK139”, 11 entries
Codes read as this program: AK139.
Conditions, from the studies’ own filings
- Prurigo, 1 study
- Chronic Urticaria, 1 study
- Nasal Polyps, 1 study
- Dermatitis, Atopic, 1 study
- Rhinitis, Allergic, Seasonal, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.